Pleas seeking RTI details on development of Covaxin: Delhi High Court makes Bharat Biotech and Central government parties

The pleas challenge an order of the Central Information Commission refusing to provide these details citing exemptions under the RTI Act for trade secrets and protection of sovereignty and integrity of India.
COVID-19 vaccine
COVID-19 vaccineRepresentative image

The Delhi High Court on Monday made Bharat Biotech and the Union Ministry of Health and Family Welfare (MoHFW) parties to the two petitions seeking information under the Right to Information (RTI) Act about the investment and costs that went into developing Covaxin, India's indigenous vaccine against COVID-19.

Want to read the full story?

We’re glad you’re enjoying this story. Subscribe to any of our plans to continue reading the story.

Already have an account? Sign In

Related Stories

No stories found.
Bar and Bench - Indian Legal news